Clinical Trial Update: An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 open study evaluating whether early Mizoribine conversion prevents BK virus nephropathy in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bk Virus Nephropathy
• Kidney Transplant Recipients

Drugs mentioned

• Mizoribine (mizoribine)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Kidney Transplant Recipients, BK Virus | Phase 4 | Status: UNKNOWN